文献速递前列腺癌

瑞典当代队列根治性前列腺切除术后死亡率与SPCG-4随机试验的匹配比较

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study.
PubMed 文献 · BJU Int · 2018-10-25

该研究通过倾向性评分匹配,比较SPCG-4试验根治性前列腺切除(RP)组与瑞典国家前列腺癌登记库(NPCR)1998-2006年治疗男性的前列腺癌死亡率和全因死亡率。结果显示,按原始Gleason分级分组匹配时,NPCR 2005-2006年男性前列腺癌死亡风险为SPCG-4的一半(HR 0.46,95%CI 0.19-1.14);将NPCR男性Gleason分级分组上调一级后匹配,差异减小(HR 0.73,95%CI 0.36-1.47)。结论认为SPCG-4的RP结局不能直接外推至当代,主要因分级膨胀和分级迁移,校正分级变化后结局相似。

要点

  • SPCG-4试验RP结局不能直接外推至当代人群,主要因分级膨胀和分级迁移。
  • 按原始Gleason分级匹配,当代NPCR男性前列腺癌死亡风险为SPCG-4的一半(HR 0.46,95%CI 0.19-1.14)。
  • 校正分级迁移后,SPCG-4与NPCR的RP结局相似(HR 0.73,95%CI 0.36-1.47)。

核心结论

  • SPCG-4试验中根治性前列腺切除术后的结局不能直接应用于当代男性,主要由于分级膨胀和分级迁移。
  • 通过校正分级变化后,SPCG-4与NPCR中根治性前列腺切除术后的结局相似。
  • 比较历史试验与当前治疗时,必须考虑检测、诊断和治疗的时间变化。

研究设计与样本

  • 倾向性评分匹配分析,比较SPCG-4试验根治性前列腺切除组与瑞典国家前列腺癌登记库(NPCR)1998-2006年治疗的匹配男性。
  • 计算前列腺癌死亡率和全因死亡率的累积发生率,采用Cox比例风险回归估计风险比(HR)和95%置信区间(CI)。
  • 匹配方式包括按原始Gleason分级分组(GGG)匹配,以及将NPCR男性GGG上调一级后匹配。

主要发现

  • 按原始GGG匹配,NPCR 2005-2006年治疗男性前列腺癌死亡风险为SPCG-4的一半(HR 0.46,95%CI 0.19-1.14)。
  • 将NPCR男性GGG上调一级后匹配,差异减小(HR 0.73,95%CI 0.36-1.47)。

关键数值与推荐

  • 按原始GGG匹配:前列腺癌死亡率HR 0.46(95%CI 0.19-1.14),对象为NPCR 2005-2006年治疗男性对比SPCG-4。
  • 按上调一级GGG匹配:前列腺癌死亡率HR 0.73(95%CI 0.36-1.47),对象为NPCR男性对比SPCG-4。

临床怎么用

  • 解读SPCG-4等历史试验的RP结局时,需考虑分级膨胀和分级迁移对当代决策的影响。
  • 校正分级变化后历史试验与当代队列RP结局相似,支持在考虑检测诊断治疗变化后谨慎外推历史证据。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate if results in terms of absolute risk in mature randomised trials are relevant for contemporary decision-making. To do so, we compared the outcome for men in the radical prostatectomy (RP) arm of the Scandinavian Prostate Cancer Group Study number 4 (SPCG-4) randomised trial with matched men treated in a contemporary era before and after compensation for the grade migration and grade inflation that have occurred since the 1980s. PATIENTS AND METHODS: A propensity score-matched analysis of prostate cancer mortality and all-cause mortality in the SPCG-4 and matched men in the National Prostate Cancer Register (NPCR) of Sweden treated in 1998-2006 was conducted. Cumulative incidence of prostate cancer mortality and all-cause mortality was calculated. Cox proportional hazards regression analyses were used to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for a matching on original Gleason Grade Groups (GGG) and second, matching with GGG increased one unit for men in the NPCR. RESULTS: Matched men in the NPCR treated in 2005-2006 had half the risk of prostate cancer mortality compared to men in the SPCG-4 (HR 0.46, 95% CI 0.19-1.14). In analysis of men matched on an upgraded GGG in the NPCR, this difference was mitigated (HR 0.73, 95% CI 0.36-1.47). CONCLUSIONS: Outcomes after RP for men in the SPCG-4 cannot be directly applied to men in the current era, mainly due to grade inflation and grade migration. However, by compensating for changes in grading, similar outcomes after RP were seen in the SPCG-4 and NPCR. In order to compare historical trials with current treatments, data on temporal changes in detection, diagnostics, and treatment have to be accounted for.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Cazzaniga W, Garmo H, Robinson D, et al. Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study. BJU Int. 2018. PMID: 30253031. doi:10.1111/bju.14563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。